Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 560Neoplasms 504Carcinoma, Non-Small-Cell Lung 421Prostatic Neoplasms 331Colorectal Neoplasms 315Lung Neoplasms 284Neoplasm Metastasis 238Leukemia, Myeloid, Acute 222Ovarian Neoplasms 206Pancreatic Neoplasms 196Multiple Myeloma 186Squamous Cell Carcinoma of Head and Neck 141Stomach Neoplasms 140Recurrence 140Brain Neoplasms 139Melanoma 134Carcinoma, Hepatocellular 132Endometrial Neoplasms 128Glioblastoma 126Precursor Cell Lymphoblastic Leukemia-Lymphoma 117Triple Negative Breast Neoplasms 116Hematologic Neoplasms 104Head and Neck Neoplasms 103Carcinoma, Renal Cell 102Urinary Bladder Neoplasms 99Lymphoma 99Sarcoma 96Glioma 96Esophageal Neoplasms 92Uterine Cervical Neoplasms 88

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Drug Resistant Epilepsy × 90 days × Clear all
NCT06724029 2026-03-30

NEON

Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta

Recruiting
4,500 enrolled

Drug Resistant Epilepsy, Aneurysm, Arteriovenous Malformations, Depression, Facial Pain, Hematoma, Subdural, Hydrocephalus, Hydrocephalus, Normal Pressure, Moyamoya Disease, Muscle Spasticity, Neuralgia, Obsessive-Compulsive Disorder, Subarachnoid Hemorrhage, Tremor, Trigeminal Neuralgia, Dystonic Disorders, Hematoma, Epidural, Spinal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡